Your Health, We Care
Lenacapavir, in combination with other antiretroviral drugs, is indicated for the treatment of heavily treated adult HIV-1-infected patients with multidrug resistance whose current antiretroviral treatment regimens have failed due to drug resistance, intolerance, or safety considerations.
FDA，2024.11
